Zacks Investment Research on MSN

Monte Rosa Therapeutics (GLUE) Reports Q3 Loss, Tops Revenue Estimates

Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.29 per share a year ago. These ...
The Brighterside of News on MSN

3D printing 'glue gun' heals fractures by printing living bone in real time

During a complicated bone surgery, every second matters. A handheld 3D bone printer, similar to a glue gun, can print living ...